COPD is caused by damage to the lungs or airways that can lead ... “There’s a variety of different inhalers to use for that, ...
Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.
Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...
Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...